NewsCoronavirus

Actions

EU: Benefits of J&J vaccine outweigh risks despite possible link to rare clotting condition

Johnson & Johnson COVID-19 Vaccine
Posted
and last updated

The European Medicines Agency (EMA) on Tuesday said that the overall benefit-risk for Johnson & Johnson’s COVID-19 vaccine “remains positive” despite six reports of extremely rare but severe clotting issues in the U.S.

In addition, the EMA — the top medical regulatory body of the European Union — recommended adding a warning label to the vaccines packaging that lists “very rare cases of unusual blood clots with low blood platelets” as a side effect of the vaccine.

The FDA and the CDC recommended a pause in the use of the Johnson & Johnson vaccine last week after a sixth person suffered the rare clotting disorder. About 7 million people in the U.S. safely received a dose of the vaccine before the pause.

Over the weekend, President Joe Biden’s top medical adviser, Dr. Anthony Fauci, said he expects the Johnson & Johnson pause to be lifted later this week.

This story is breaking and will be updated.

,

Weather

Daily Forecast

View Hourly Forecast

Day

Conditions

HI / LO

Precip

Sunday

07/06/2025

Sunny

98° / 70°

0%

Monday

07/07/2025

Sunny

101° / 68°

0%

Tuesday

07/08/2025

Sunny

100° / 69°

0%

Wednesday

07/09/2025

Sunny

99° / 71°

0%

Thursday

07/10/2025

Sunny

101° / 74°

0%

Friday

07/11/2025

Sunny

106° / 76°

0%

Saturday

07/12/2025

Sunny

105° / 75°

0%

Sunday

07/13/2025

Sunny

105° / 76°

0%